143 related articles for article (PubMed ID: 31279299)
1. Synthesis and biological evaluation of celastrol derivatives as anti-ovarian cancer stem cell agents.
Li X; Ding J; Li N; Liu W; Ding F; Zheng H; Ning Y; Wang H; Liu R; Ren S
Eur J Med Chem; 2019 Oct; 179():667-679. PubMed ID: 31279299
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of novel C-29 carbamate celastrol derivatives as potent and selective cytotoxic compounds.
Figueiredo SAC; Salvador JAR; Cortés R; Cascante M
Eur J Med Chem; 2017 Oct; 139():836-848. PubMed ID: 28865279
[TBL] [Abstract][Full Text] [Related]
3. Novel celastrol derivatives with improved selectivity and enhanced antitumour activity: Design, synthesis and biological evaluation.
Figueiredo SAC; Salvador JAR; Cortés R; Cascante M
Eur J Med Chem; 2017 Sep; 138():422-437. PubMed ID: 28688281
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterisation of celastrol derivatives as potential anticancer agents.
Zhang HJ; Zhang GR; Piao HR; Quan ZS
J Enzyme Inhib Med Chem; 2017 Dec; 33(1):190-198. PubMed ID: 29231066
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and antitumor evaluation of novel celastrol derivatives.
Xu M; Li N; Zhao Z; Shi Z; Sun J; Chen L
Eur J Med Chem; 2019 Jul; 174():265-276. PubMed ID: 31051401
[TBL] [Abstract][Full Text] [Related]
6. Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells.
Li X; Wang H; Ding J; Nie S; Wang L; Zhang L; Ren S
Eur J Pharmacol; 2019 Jan; 842():146-156. PubMed ID: 30389635
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Biological Evaluation of a Series of Novel Celastrol Derivatives with Amino Acid Chain.
Pang C; Luo J; Liu C; Wu X; Wang D
Chem Biodivers; 2018 May; 15(5):e1800059. PubMed ID: 29633499
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.
Liu X; Li B; Zhang Z; Wei Y; Xu Z; Qin S; Liu N; Zhao R; Peng J; Yang G; Qi M; Liu T; Xie M; Liu S; Gao X; Lu C; Zhu L; Long X; Kang H; Sun T; Zhou H; Wei M; Yang G; Yang C
J Med Chem; 2018 Dec; 61(23):10814-10833. PubMed ID: 30433783
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
10. Discovery of semisynthetic celastrol derivatives exhibiting potent anti-ovarian cancer stem cell activity and STAT3 inhibition.
Li N; Li C; Zhang J; Jiang Q; Wang Z; Nie S; Gao Z; Li G; Fang H; Ren S; Li X
Chem Biol Interact; 2022 Oct; 366():110172. PubMed ID: 36096161
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and evaluation of antitumor activity of novel C-6 sulfhydryl-substituted and 20-substituted derivatives of celastrol.
Su D; Wei RY; Yan ZM; Zhong GH; Qin XQ; Huang ST; Long JY; Zhang FL; He P; Chen ZJ; Yan YQ; Jiang N; Tang WZ
Chem Biol Drug Des; 2023 Aug; 102(2):316-331. PubMed ID: 37156601
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of celastrol derivatives as potential anti-glioma agents by activating RIP1/RIP3/MLKL pathway to induce necroptosis.
Feng Y; Wang W; Zhang Y; Fu X; Ping K; Zhao J; Lei Y; Mou Y; Wang S
Eur J Med Chem; 2022 Feb; 229():114070. PubMed ID: 34968902
[TBL] [Abstract][Full Text] [Related]
13. Optimization and biological evaluation of celastrol derivatives as Hsp90-Cdc37 interaction disruptors with improved druglike properties.
Jiang F; Wang HJ; Bao QC; Wang L; Jin YH; Zhang Q; Jiang D; You QD; Xu XL
Bioorg Med Chem; 2016 Nov; 24(21):5431-5439. PubMed ID: 27647369
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 3- and 29-substituted celastrol derivatives and structure-activity relationship studies of their cytotoxic activities.
Shan WG; Wang HG; Chen Y; Wu R; Wen YT; Zhang LW; Ying YM; Wang JW; Zhan ZJ
Bioorg Med Chem Lett; 2017 Aug; 27(15):3450-3453. PubMed ID: 28587825
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel NO-releasing celastrol derivatives with Hsp90 inhibition and cytotoxic activities.
Li N; Xu M; Bao N; Shi W; Li Q; Zhang X; Sun J; Chen L
Eur J Med Chem; 2018 Dec; 160():1-8. PubMed ID: 30316059
[TBL] [Abstract][Full Text] [Related]
16. 2-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells.
Serbian I; Siewert B; Al-Harrasi A; Csuk R
Eur J Med Chem; 2019 Oct; 180():457-464. PubMed ID: 31330447
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of β-boswellic acid derivatives as cytotoxic and apoptotic agents.
Kumar A; Qayum A; Sharma PR; Singh SK; Shah BA
Bioorg Med Chem Lett; 2016 Jan; 26(1):76-81. PubMed ID: 26608550
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of celastrol derivatives as anticancer agents.
Tang WJ; Wang J; Tong X; Shi JB; Liu XH; Li J
Eur J Med Chem; 2015 May; 95():166-73. PubMed ID: 25812966
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Urea Derivatives of Celastrol as Selective Peroxiredoxin 1 Inhibitors against Colorectal Cancer Cells.
Li Y; Zhu Y; Shang FF; Xu L; Jiang D; Sun B; Zhang L; Luo C; Zhang A; Zhang H; Ding C
J Med Chem; 2024 May; 67(9):7176-7196. PubMed ID: 38679872
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moiety.
Liu MC; Yang SJ; Jin LH; Hu DY; Xue W; Song BA; Yang S
Eur J Med Chem; 2012 Dec; 58():128-35. PubMed ID: 23124210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
